VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NASDAQ:QGEN) (FWB:QIA) today announced an expansion of its strategic partnership with the United Kingdom’s Veterinary Laboratories Agency (VLA), one of the world’s leading research institutions in veterinary science. Under the terms of the agreement, QIAGEN has received the exclusive rights to commercialize three new PCR-based tests for the detection of widespread bacterial diseases in horses. Financial details have not been disclosed.
